Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia.

Haematologica

Volumn 91, Issue 12 Suppl, 2006, Pages

  Buccisano, Francesco ^a   Maurillo, Luca ^a   Del Poeta, Giovanni ^a   Gattei, Valter ^a   Amadori, Sergio ^a   Venditti, Adriano ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE DISEASE; ADULT; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD; BLOOD CELL COUNT; DISEASE FREE SURVIVAL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTIMODALITY CANCER THERAPY; MYELOID LEUKEMIA; NOTE; PATHOLOGY; REMISSION; SURVIVAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; NEOPLASM, RESIDUAL; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 37749045976     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: None     Document Type: Note

References (0)